Editor Profiles

Dr. MARIANA BONJIORNO MARTINS currently working as Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences (FCM), University of Campinas (Unicamp), 126, Tessalia Vieira de Camargo St., Campinas, SP, Brazil. She obtained Graduation in Bachelor and Full Degree in Biological Sciences, Master and PhD in Sciences by the Department of Medical Clinic of Unicamp. Currently postdoctoral fellow in the field of molecular biology and biochemistry. Possessing knowledge in the area of Human, Medical and Molecular Genetics. She has experience as Guest Researcher.

I obtained my Master degree in Microbiology, Department of Microbiology, Wuhan University in 1999 and Ph.D in Genetics, Institute of Hydrobiology, The Chinese Academy of Sciences in 2002, respectively. Served as editorial member board and reviewer of more than 10 international journals. Focusing on chondrogenesis and osteogenesis of mesenchymal stem cells, including bone and cartilage disease modeling and drug screening, direct conversion of human fibroblasts into osteoblast-like cells, directed differentiation of iPS toward MSCs, gene and cell therapy for cartilage regeneration etc.

I am Dr. Thiagarajan Venkatesan currently working as an Associate Research Scientist in Rumbaugh Goodwin Institute for Cancer Research, Nova Southeastern University, Florida, USA. I did my Ph.D in Microbiology-Botany from University of Madras, India. I have also worked as a Research Scientist in R&D in Bharat Biotech and involved in the development of recombinant human vaccine against cancer. My work involved upstream and the downstream processing of cancer related viral antigens to the pilot and large scale levels. Currently I am doing the development of therapeutic proteins against selected targets in cancers. Also I am analyzing the gene expression pattern in highly aggressive cancers. I am an Associate member of the American Association for Cancer Research. I have published research articles in international peer reviewed journals and also presented papers in National and International conferences.

Dr. Aaron Lisberg is a hematologist and medical oncologist who is an Assistant Professor of Medicine at The University of California, Los Angeles. He specializes in the emerging field of immunotherapy, with a specific focus on malignancies of the lung. He is board certified in internal medicine, hematology and medical oncology. In addition to his clinical work, Dr. Lisberg conducts research on immunotherapy, and factors that might predict either a response or toxicity to immune checkpoint inhibition in lung cancer. He also conducts research on the synergistic nature of radiation and immune-based therapies. Dr. Lisberg received his medical degree from the University of Minnesota Medical School, where he was elected to the AOA honor society. He then completed his internal medicine residency at The University of Washington in Seattle, followed by his hematology/oncology fellowship at UCLA. He grew up in Minneapolis, Minnesota, and received his Bachelor of Arts degree in biology from Grinnell College. Research Interest: Immunotherapy, Oncology, Lung Cancer

Dr. Nitin Sharma currently works at the HCG cancer Centre Ahmedabad. He has got her M.D. from Sardar Patel university Anand ,Gujrat, India.

Dr. Wei Wei, is a Assistant Professor School of Chinese Medicine, Hong Kong Baptist University, 7 Baptist University Road, Kowloon Tong, Hong Kong, China

Nicola Maurea is currently working a Chief, Division of Cardiology, INT Pascale Naples Italy. He got M.D from University Federico II Naples, Italy.

Rahul Mirlekar is an immunologist with a deep and long-lasting interest in how the immune response shapes cancer and autoimmune disease. Rahul Mirlekar is leveraging the immunosuppressive populations that restrain anti-tumor immunity in pancreatic cancer and malignant melanoma, with developing new immune based therapy options for these deadly malignancies. He is acquired the knowledge, training and experience in the field of immunology to effectively carry out research in basic immunology for better translation of research findings to clinical applications. He worked on molecular mechanism of T cell differentiation associated with auto-inflammatory responses. He proposed that the regulatory T cell (Treg) function and cytokine signaling dictates the balance between Treg and Th17 cells. In addition to many first-author publications, Rahul Mirlekar have written several collaborative co-authored peer-reviewed publications in collaboration during my research studies. Currently, Rahul Mirlekar is working on cellular and molecular mechanisms of B cell-mediated immune responses during pancreatic cancer and malignant melanoma initiation and progression. Research interest: Cancer cells, Regulatory T cell (Treg) B cells

Minghua Wu is currently working a Professor in Laboratory of Molecular, Cellular Genetics, Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, China. She got Ph.D. from Ph.D., Major-Oncology of pathophysiology, Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, Changsha, Hunan, P.R. China Research interest: Cancer Molecular, Cell Biology, Gene expression

Daniela Capdepon MD, graduate of the University F. Medical Barceló in 2001 with honors and highest academic average. Completed residency in Internal Medicine at the Municipal hospital and COBA oriented Graduate Clinical Oncology from 2002 to 2004. Then she began to study the specialty of Clinical Oncology at the University of Salvador, trained in gastric tumors in Udaondo Hospital, Hospital Marie Curie Cancer Center and Henry Moore and learned to prepare and deliver chemotherapies and concurrences to form the pallium Center for palliative treatment of pain. Graduated in the specialty of clinical oncologist and palliative medicine subspecialty in Pain in 2006 of Salvador University, Buenos Aires. Works as in Municipal Hospital and Italian Society of Zarate and Campana. Fellow in Fundaleu as subinvestigadora in Oncohematology and trained in liquid tumors, LLC, ALL MM, NHL LH. during 2006-2007. In 2008 she built her own Cancer Center and works as a medical director, in Campana Cancer Center, where cancer care is done in outpatient chemotherapy treatments and pain and palliative treatments. The cancer centre works with a specialized team with various advanced research in the field of oncology. Research interest: Tumors, Cancer, Oncology and Oncohematology